Literature DB >> 9829797

Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

H Lannert1, S Hoyer.   

Abstract

Drastic abnormalities have been demonstrated to occur in cerebral glucose and energy metabolism in sporadic Alzheimer's disease, pointing to a primary disturbance in neuronal insulin and insulin receptor signal transduction and contributing to the causation of dementia. The compound streptozotocin (STZ) is known to inhibit insulin receptor function. The study was designed to investigate whether intracerebroventricularly (icv) applied STZ would inhibit neuronal insulin receptor function and would induce changes in both behavior and neuronal energy metabolism. Adult rats with icv-injected STZ developed long-term and progressive deficits in learning, memory, and cognitive behavior, indicated by decreases in working and reference memory in the holeboard task and the passive avoidance paradigm, along with a permanent and ongoing cerebral energy deficit. This animal model may be appropriate for investigations related to sporadic Alzheimer's dementia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9829797     DOI: 10.1037//0735-7044.112.5.1199

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  129 in total

1.  Role for neuronal insulin resistance in neurodegenerative diseases.

Authors:  Markus Schubert; Dinesh Gautam; David Surjo; Kojihiko Ueki; Stephanie Baudler; Dominic Schubert; Tatsuya Kondo; Jens Alber; Norbert Galldiks; Eckehardt Küstermann; Saskia Arndt; Andreas H Jacobs; Wilhelm Krone; C Ronald Kahn; Jens C Brüning
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

Review 2.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

3.  Neuromodulatory effect of propentofylline on rat brain under acute and long-term hypoperfusion.

Authors:  K Plaschke; M Grant; M A Weigand; J Züchner; E Martin; H J Bardenheuer
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

4.  Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.

Authors:  Tristano Pancani; Jeremiah T Phelps; James L Searcy; Michael W Kilgore; Kuey-Chu Chen; Nada M Porter; Olivier Thibault
Journal:  J Neurochem       Date:  2009-05-11       Impact factor: 5.372

Review 5.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

Review 6.  Models and mechanisms for hippocampal dysfunction in obesity and diabetes.

Authors:  A M Stranahan
Journal:  Neuroscience       Date:  2015-04-28       Impact factor: 3.590

7.  Drotaverine Inhibitor of PDE4: Reverses the Streptozotocin Induced Alzheimer's Disease in Mice.

Authors:  Samra Nazir; Fareeha Anwar; Uzma Saleem; Bashir Ahmad; Zohaib Raza; Maham Sanawar; Artta Ur Rehman; Tariq Ismail
Journal:  Neurochem Res       Date:  2021-04-20       Impact factor: 3.996

Review 8.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

Review 9.  Type 2 diabetes and risk of cognitive impairment and dementia.

Authors:  Rachel A Whitmer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

10.  Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model.

Authors:  Ahmet Turan Isik; Turgay Celik; Gokhan Ulusoy; Onder Ongoru; Birsen Elibol; Huseyin Doruk; Ergun Bozoglu; Hakan Kayir; Mehmet Refik Mas; Serif Akman
Journal:  Age (Dordr)       Date:  2008-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.